000 01459 a2200433 4500
005 20250513115042.0
264 0 _c19970424
008 199704s 0 0 eng d
022 _a0041-1345
024 7 _a10.1016/s0041-1345(96)00151-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSheil, A G
245 0 0 _aLymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation.
_h[electronic resource]
260 _bTransplantation proceedings
_c
300 _a825-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aActuarial Analysis
650 0 4 _aAustralia
650 0 4 _aConfidence Intervals
650 0 4 _aFollow-Up Studies
650 0 4 _aHeart Transplantation
_xmortality
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aKidney Transplantation
_xmortality
650 0 4 _aLiver Transplantation
_xmortality
650 0 4 _aLymphoma, Non-Hodgkin
_xepidemiology
650 0 4 _aNeoplasms
_xepidemiology
650 0 4 _aPostoperative Complications
650 0 4 _aRegistries
650 0 4 _aRetrospective Studies
650 0 4 _aSurvival Rate
650 0 4 _aTime Factors
700 1 _aDisney, A P
700 1 _aMathew, T H
700 1 _aLivingston, B E
700 1 _aKeogh, A M
773 0 _tTransplantation proceedings
_gvol. 29
_gno. 1-2
_gp. 825-7
856 4 0 _uhttps://doi.org/10.1016/s0041-1345(96)00151-0
_zAvailable from publisher's website
999 _c9105067
_d9105067